Management of Hard Swollen Vulva
The appropriate management of a hard swollen vulva requires immediate identification of the underlying cause through focused clinical examination and targeted diagnostic workup, with treatment directed at the specific etiology—whether infectious, traumatic, inflammatory, or neoplastic.
Initial Clinical Assessment
Key Diagnostic Features to Evaluate
Assess for infectious causes by examining for pruritus, erythema, white discharge (suggesting vulvovaginal candidiasis with normal pH ≤4.5), or malodorous yellow-green discharge with irritation (indicating trichomoniasis) 1, 2.
Evaluate for traumatic etiology, particularly vulvar hematoma, which most commonly occurs after vigorous sexual intercourse in non-obstetric settings and presents with acute pain, tenderness, and unilateral labial swelling 3.
Consider pregnancy-related causes if applicable, as vulvar edema occurs in up to 80% of pregnant women and can be associated with severe pre-eclampsia, hypoproteinemia, or occur postpartum (affecting the vulva more frequently than pre-pregnancy) 4, 5.
Rule out lichen sclerosus, especially in postmenopausal women presenting with depigmented, burning, and painful vulvovaginal areas, as this carries malignant transformation risk and requires biopsy if diagnosis is uncertain 6.
Examine for neoplastic lesions, particularly in older patients or those with chronic HPV infection, tobacco use, or immunosuppression, as vulvar cancer (90% squamous cell carcinoma) can present with vulvar masses 4.
Diagnostic Workup
Laboratory and Imaging Studies
Obtain vaginal pH testing and wet mount microscopy to differentiate between candidiasis (pH <4.5, yeasts/pseudohyphae visible), trichomoniasis (elevated pH, motile trichomonads), or bacterial vaginosis (pH >4.5, clue cells) 1, 2.
Order pelvic CT imaging when traumatic hematoma is suspected based on history of recent intercourse or trauma, as imaging can confirm hemorrhagic fluid collection and guide surgical intervention if needed 3.
Perform punch biopsy if inflammatory dermatoses (lichen sclerosus, lichen planus) are suspected, disease fails to respond to initial treatment, or there is any concern for neoplastic change—this is mandatory to avoid missing malignancy 4, 6.
Check for systemic causes in pregnant patients with massive vulvar edema by evaluating blood pressure, proteinuria, and serum albumin levels to identify pre-eclampsia or hypoproteinemia 5.
Treatment Algorithm
For Infectious Causes
Treat uncomplicated vulvovaginal candidiasis with fluconazole 150 mg oral single dose or topical azole therapy (clotrimazole 1% cream 5g intravaginally for 7-14 days), achieving 80-90% cure rates 1, 2.
Use only 7-day topical azole therapy in pregnant women with candidiasis, as oral fluconazole is contraindicated due to associations with spontaneous abortion and birth defects 1, 2.
Prescribe oral metronidazole for trichomoniasis, which achieves 90-95% cure rates, and ensure treatment of sexual partners to prevent reinfection 1, 2.
For Traumatic Causes
Manage vulvar hematoma with surgical evacuation when significant blood collection is confirmed on imaging (typically 150+ cc of clot), followed by compression and monitoring for reaccumulation 3.
Apply conservative management with compression and lymphatic massage for smaller hematomas or generalized vulvar edema without large fluid collections 7.
For Inflammatory Dermatoses
Initiate ultrapotent topical corticosteroid therapy with clobetasol propionate ointment once nightly for 4 weeks, then alternate nights for 4 weeks, then twice weekly for the third month if lichen sclerosus is confirmed 4.
Continue topical corticosteroids following any surgical intervention (such as circumcision for phimosis) to prevent Koebnerization and further scarring 4.
For Pregnancy-Related Edema
Treat underlying pre-eclampsia when massive vulvar edema is associated with hypertension and proteinuria, as this typically results in spectacular regression of edema within 15 days of blood pressure normalization 5.
Consider prophylactic plasma-derived C1 inhibitor (pdhC1INH) in pregnant patients with hereditary angioedema and history of frequent severe attacks, as this appears safe and effective during pregnancy 4.
For Neoplastic Lesions
- Refer for surgical evaluation and sentinel lymph node mapping if vulvar cancer is confirmed, as inguinofemoral lymph node status is the most important prognostic factor 4.
Critical Pitfalls to Avoid
Never delay biopsy when lichen sclerosus is suspected, as approximately 4% of cases progress to squamous cell carcinoma, and early detection is crucial 4, 6.
Do not prescribe long-term ketoconazole without hepatotoxicity monitoring, as clinically important liver enzyme abnormalities occur in 1:10,000 to 1:15,000 exposed persons 4, 6.
Avoid self-medication with over-the-counter antifungals unless the patient has been previously diagnosed with the same condition, and instruct patients to seek medical care if symptoms persist after OTC treatment or recur within 2 months 4, 1.
Do not assume benign etiology in postmenopausal women without thorough evaluation, as vulvar cancer risk increases with age and chronic inflammatory conditions 4.
Special Considerations for High-Risk Populations
In HIV-infected women, treat vulvovaginal candidiasis with the same regimens as immunocompetent patients, but recognize that lower CD4+ counts are associated with increased VVC rates and potentially more severe presentations 1, 2.
For patients with recurrent symptoms (≥4 episodes/year), obtain vaginal cultures to identify non-albicans Candida species and consider maintenance antifungal regimens for 6 months 1, 2.